This topic contains a solution. Click here to go to the answer

Author Question: What does interaction mean in a factorial design? What will be an ideal ... (Read 49 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
What does interaction mean in a factorial design?
 
  What will be an ideal response?

Question 2

Events or influences other than the experimental treatment itself may occur between a pretest and a posttest that may affect the dependent variable. This threat is called
 
  a. mortality.
  b. history.
  c. regression.
  d. diffusion.
  e. Hawthorne effect.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

elizabethrperez

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Interaction refers to an effect that occurs in a factorial design when the influence of one factor depends on the level of a second factor. For example, a treatment may be effective with boys but not girls.

Answer to Question 2

B




newbem

  • Member
  • Posts: 579
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


connor417

  • Member
  • Posts: 329
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library